johnson & johnson was up against the variants from the south african lineage which might reduce some effectiveness. but johnson & johnson vaccine is greater than 80% effective at preventing severe illness and death and 100% effective of preventing death alone if you look at that. benefits of j&j is one shot, cheaper, can sit in normal refrigerator for months, that's a game changer getting the vaccine out to resource poor rural areas and improving the distribution in equitable way. >> how important is it that it's one-shot vaccine? talked about people having to come back for second shot, how important is it this is one shot and can be stored in normal refrigerators to help poor and rural areas. >> it's really important with respect to distribution, making sure more people are getting the shot. when we say johnson & johnson announced 4 million shots next week, 100 million by summer, that's that many americans getting the vaccine. on global scale we're going to get that many more people protected. one thing important for people to understand, there is a trial going on now to look to see two doses of the johnson &

trials, just in the united states the johnson & johnson vaccine appear to be 72% effective against moderate to severe covid-19. and some differences between johnson & johnson's trials and moderna and pfizer's trials are that moderna and pfizer started in the spring and summer. their trials were much earlier during the pandemic whereas johnson & johnson was a little bit later. and johnson & johnson happened as we identified some of these coronavirus variants emerging. so that might answer some questions when it comes to the differences. but overall doctors say that if you are able to get any of these vaccines the one right for you is the one that's available. there's no reason to think one is better than the other and overall johnson & johnson did show to be effective against moderate to severe disease. here's what dr. paul offitt had to say about this. he's actually a member of the fda advisory committee that recommended the vaccine yesterday. have a listen. >> we'll see whether there will be a second dose recommendation. one dose will keep you out of the hospital, keep you out of the intensive care unit and keep you out of the morgue. >> so you

if an eua is issued, we anticipate allocating 3 million to 4 million doses of johnson & johnson vaccine next trick. johnson & johnson aims to deliver more than 20 million doses by the end of march. we are working with the company to accelerate the pace and timeframe by which they deliver the full 100 million doses, which is required by contract or the end of june. while we await the fda's decision, we want the american people to know that we are doing the work so that if the eua is granted, we will waste no time getting this life-saving vaccine into the arms of americans. with that, let me turn it over to dr. wolinsky to talk about the state of the pandemic. >> thank you. we continue to see trends heading in the right direction. in the past week, average daily cases declined 25% to approximately 64,000 cases per day. this is slightly less than the former peak of 67,000 daily cases reported last july. while this is good news, cases still remain high and we continue to watch this data closely. we also continue -- see continue to climb the hospital admissions for the most recent week. an average of 6500 patie

the johnson & johnson vaccine can be stored in a refrigerator for up to three months. two vaccines need to be kept in ultra cold freezers. its overall efficacy rate is 72% in the u.s. and when it

johnson jab made with mrna technology? what is the difference? guest: it's a different technology. the way the johnson & johnson vaccine is made, they constructed a virus that can cause colds like illnesses. they have taken that and made it so it can't replicate in normal human cells. what that virus has had inserted and it, the genetic information for the most important protein, it shows that protein to your cells. it doesn't replicate. it makes your immune system ready to defend against it when that virus comes along. it is similar in the sense that both teach your immune session of to recognize and fight the virus. it uses a replication virus instead of rna to do that. host: we have noticed from new data from the cdc that shows nearly 3 million americans never showed up for their second dose of the pfizer or the moderna vaccine in time. are those americans who did not show up in time for their second dose of the vaccine, are they still protected? guest: they are probably not fully protected. we have limited information on that. clinical studies, everybody got both doses of the vaccine. what we do know is bet

& johnson provides a really important tool in the arsenal. >> how quickly could we see johnson & johnson shot in the arms? well, assuming that all goes well with the cdc and we have a distribution strategy, by next week we could start seeing johnson & johnson going out. of course, the limiting thing is supply. so it looks like we may have around 4 million doses going out by next week. but it seems that johnson & johnson is prepared to ramp that up very quickly so we could have more on the order of 40 million by the end of march. so going through the spring, having that extra supply will be very valuable and really gives us a lot of hope for how the summer into the fall could be transformat. >> does that mo mean next week there could be shots in the arms of the johnson & johnson vaccine? or do you expect a delay? >> well there could be as we have seen. we've had challenging in distributes to states and then to distribution sites, and getting all the logistics of actually getting the vaccine to collide with people's arms. however a lot of the bugs have been worked out with distribution of

johnson & johnson vaccine. the newest weapon against covid here in the u.s., johnson & johnson's vaccine 85% effective against severevid. 100% effective at preventing hospitalizations and deaths. it could be stored in normal refrigeration. how many doses will be shipped right away? how many next month? and what you need to know about this one-shot vaccine that many are calling a game changer. >>> also tonight, the biden administration declassifying the report on the murder of u.s.-based journalist jamal khashoggi, pointing the blame at saudi arabia's crown prince, accusing him of approving the brutal attack. the sanctions just issued

johnson & johnson's one-dose vaccine. >> if an e.u.a. is issued, we anticipate allocating three million to four million doses of johnson & johnson's vaccineweek. >> reporter: the f.d.a. confirms that j & j's vaccine is slightly less effective than the moderna and pfizer shots overall but, showed 85% efficacy against severe illness and complete protection against covid-19 deaths, 28 days after getting the shot. it also works better in the u.s. than in south africa, where a more contagious variant is dominant. >> reporter: johnson & johnson's vaccine only needs to be kept at normal refrigeration temperatures and stored for three months. >> i think the johnson & johnson vaccine is a very important new development. it does show very, very good protection against serious illness, hospitalization and deaths. >> reporter: to keep down infections, the biden administration is planning to ship 25 million masks to community health centers and food banks. also tonight, moderna announcing it is preparing clinical trials for a south african variant booster shot. researchers in california say there is a home-grown variant there too, which not only w res

johnson & johnson, take that. maybe you can get a booster shot of johnson & johnson in months to come, or even in another vaccine inome. get whatever you can now to get some immunity, some protection for you and for people around u you. >> how nervous or excited are you to find out if you got the placebo or the vaccine itself? >> i'm told at some point this week hopefully i'll be getting a call telling me what i got. of the two dose trial, i got either two of the placebo or two of the vaccine. if i got the placebo, i'll be very happy to finally get the vaccine. >> we're excited to find out your results as well. thank you for being with us. you always have wonderful information to help us through the pandemic. thank you. >>> coming up, a second former aide has come forward accusing new york governor andrew cuomo of sexual harassment. we have the latest on the new accusations and the investigation. plus, alarming new details about the crash that killed nba superstar koeb buy bryant. you're live in the "cnn newsroom." so when my windshield broke... >> woman: what?! >> vo: ...i searched for someone who really knew my c

johnson & johnson vaccine is 85% effective at preventing severe illness. it will make it easier to distribute across the state is the basic storage requirement. >> there's not a storage issue and there's not the need for the dramatic go dramatic cold degrees the other vaccines need. >> reporter: johnson & johnson says they're on track to deliver 100 million doses by the end of june. governor gavin newsom says california is set to receive the first batch next week if authorized. >> we anticipate receiving 380,000, 380,300 doses of the j & j vaccine next week, and predictably over the next three weeks. >> reporter: another aspect that will impact distribution is the statewide system. by march 31st, california is expected to be switched over to a centralized vaccine appointment and delivery system by blueshield. dr. michael wasserman is part of the california vaccine advisory committee. he says more doses will be able to reach vulnerable populations now. >> primary care physicians who know who their patients are that need to be vaccinated, hopefully, we'll be able to get the vaccine into their offices. >> reporter: with more vaccine available, dr. gans says we have a better chance at beating the virus and reaching herd immunity faster. >> only about, i think, 13% of our population is ac

johnson & johnson now being the third, it is a step forward in the fight against covid-19. and with the amount of vaccine doses that will be made available as soon as the cdc gives its recommendation that this vaccine can be used, we are going to see the capacity for vaccinations increase by about 25% with the rollout of the johnson & johnson vaccine. but before shots start going into arms, we do need to hear from the cdc panel that you mentioned. they're meeting right now to discuss who this vaccine is best for and to recommend how it can be used. the fda told us, yes, it can be used with authorization, but the cdc is going to tell us how. in the meantime, here is the rollout plan. johnson & johnson has 3.9 million doses expected to be available immediately, according to the company, and among those doses, they will be allocated to state and local jurisdictions, retail pharmacies, federally qualified health centers and community vaccine centers. so that's the rollout we'll see in the next few days, but again, we first need to hear from the cdc on who this vaccine is recommended for. and then next we also are going to hear more discussions from the cdc today as this advisory committee panel continues around what the data tell us about the johnson & johnson vaccine. this vaccine was tested in about 44,000 people i

johnson & johnson obviously yesterday applied for the emergency use authorization. so given that, what is the time line? when do you think it will be approved? and when do you think it will roll out and get to people. >> kristen we're talking about this. but you have no excuse now for missing any of the second round of two truths and a lie. >> okay. pressure. >> johnson & johnson, their early data, it was all over the place in terms of which country they were providing the efficacy data but we saw 72% in united states. 85% at preventing the severe symptoms which is important news. we talked about the fact that it's one shot, cheaper and doesn't have the deep freeze requirement. now, according to the company they've already submitted an eua to the fd a, the emergency use authorization. >> um-hum. >> the fda is going to meet to talk about the data on february 26th. so if everything goes according to plan we may start to see a rollout of johnson & johnson vaccines in march. and the company said they're ready to produce hundreds of millions of doses by summer. so that could be a really big step forward in getting us to herd immunity. >> got it. okay. is the next two truths and a lie, the next round in the next block, vaccine related? because if so i'm jumping to other questions right now. >> it possibly will be. and i want to make one correction for the

johnson & johnson, also cause for hope. abc's trevor ault leads us off right here in new york. >> reporter: tonight, the fda gi the covid fiuthori johnson & jos one-shot vaccine. >> we're at the precipice of having another vaccine in our toolboxes. >> reporter: in trials, the johnson & johnson vaccine has been 100% effective against hospitalization and death. and 85% effective at preventing severe illness. while its overall effectiveness was lower than pfizer and moderna, johnson & johnson's was tested against concerning variants, and it still performed well. >> when this vaccine was tested in south africa where the south african variant is common, and when it was tested in brazil where the brazilian variant is common, it worked to keep you out of the hospital and keep you out of the morgue. i think that's really important. >> reporter: the j&j vaccine can also be kept in regular refrigerators, allowing for easier shipping and storage. our elwyn lopez is in kentucky. >> j&j says up to 4 million doses are ready to ship within days. 100 million by the end of june. many rolling out of this facility outside of louisville. >> reporter: as mu

efficacy, trials have shown some different numbers when it comes to johnson & johnson and moderna and pfizer. here is what those numbers are. johnson & johnson was studied among about 44,000 people in the u.s., south africa, and latin america. in those global trials it showed to be 66% effective against moderate to severe covid-19. 85% effective against severe covid-19. and we know that moderna and pfizer have about 95% efficacy. so those are differences in numbers. but doctors say you shouldn't necessarily think one is better than the other. there are a lot of caveats here, for instance johnson & johnson's trials were done, as we saw thee coronavirus variants emerge which could explain the differences in numbers because moderna and pfizer's trials began earlier in the pandemic. but overall the johnson & johnson trials do suggest that it is effective in preventing severe disease that requires hospitalization. and no one who got the vaccine died of covid-19. so it shows to be about 100% effective against covid-19 death. here is what dr. paul offit had to say about this. he's a member of the fad advisory committee that recommended th

johnson & johnson. they've also, biden administration officials have said that johnson and johnson was behind on their manufacturing, in part because of needing to source raw materials, but also equipment. >> sreenivasan: the administration set out some ambitious goals early on and aying what they hope to accomplish, how many people they hope to have vaccines accessible to, are we likely to hit those goals? i mean, put the number of vaccines into perspective here. >> i do think that the goals that the biden administration have announced for how many americans they want to vaccinate in the first 100 days of presidenbiden's presidency are doable. but that being said, especially when we look at pfizer and moderna, they have openly acknowledged and they will have to significantly ramp up their manufacturing capacity compared to what they have been doing historically. pfizer, for example, has about six weeks to provide 80 million doses, they provided 40 million doses in roughly two months to the u.s. government. moderna's is similar compared to what they were manufacturing in january. we know that they made about 19 mil

million dose of johnson & johnson's single-dose vaccine which is likely to receive emergency use authorization from the fda later this week. the agency today releasing data showing johnsonohnson's vaccine is safe and more than 66% effective. >> it will get to us where we need to be in terms of having most of the public vaccinated hopefully by the summer or early fall. >> the federal government also unveiling a new plan to send out 25 million masks to people who need them the most. >> in the month of march, we will begin to deliver millions of masks to food banks and community health centers around the country. many low-income americans still lack affordable access to this basic protection. >> this as weeks of declines in new covid cases continue across the country but not as steeply and not enough to eliminate concerns new variants could cause another surge. >> it could result in more of a wave in say april and may than we would have expected otherwise. >> we're in an arms race between the virus and our ability to vaccinate and shut down the avenues that it has to continue to evolve. >> reporter: weekly shipments of vaccines are getting another increase. >> we've nearly

this evening the fda granted emergency use authorization for johnson & johnson's one-shot vaccine.nced president biden's $1.9 trillion plan almost entirely along party lines. so when can you expect to get your shot or your check? from nbc news

johnson & johnson says that as soon as they get, you know, that guidance from the cdc advisory group that's when they can start moving doses out of the facility, behind me, potentially as early as the sun starts to rise tomorrow morning, within the first week johnsonohnson say they'll distribute 4 million doses of the vaccine, 20 million by tend of march, 100 million come summer, they say globally they'll distribute 1 billion doses of this vaccine by the end of the year, this vaccine is over 60% effective but when they were doing the trials studying efficacy it varied region to region. 70% eventive in the united states. in south africa, where's that much more contagious variant, under 60%. the trials and the testing for johnson & johnson, they happened at a time when we saw more recently much more contagious strains where moderna and pfizer weren't initially tested with that. the big thing to remember, next step cdc advisory board has to meet, give their guidelines and instruction for use. tomorrow morning first thing we expect to see those doses leave the facility here in kentucky and make their way to a u.p.s. distribution center. 4 million doses should be out, distributed across the united states by tend of the week. >> ellison, thank you. >>>

johnson & johnson's vaccine -- it was an easy one. >> there's ever conceivable way to expand manufacturing of the vaccine. the third vaccine, to make even more rapid progress. >> reporter: with the nation one critical step closer to distributing johnsonewly authorized vaccine, a much needed decline in the nation's new covid-19 cases and hospitalizations appears to be stalling. en friday, the head of the cdc warned the nation's seven-day average of cases is leveling out at about 66,000. that's a number that's still alarmingly high. >> we at cdc consider this a very concerning shift in the trajectory. >> reporter: adding to scientists' fears, the downward slope is ending, a rise in new virus variants threatening to reverse the progress. one such variant was detected in california and another in the northeast, likely having mutated in new york city says the nation's top infectious disease expert. >> it started out as a cluster in washington heights area, near columbia medical center. then it started to go through the other parts of the city, the other boroughs, and it's something that you want to pay attention to because it has worrisome mutations in it. >> reporter: the first shots of the johnson & johnson vaccine could be administered

& johnson vaccine from fda headquarters. >>> well, johnson & johnsoncleared a significant hurdle today with the fda advisory committee voting unanimously to approve its covid-19 vaccine. and if the fda clears it for use it will come at a time when the country is looking to boost its covid-19 vaccine supply. >> we do have a favorable vote. >> reporter: they are poised to get a third covid-19 vaccine after an independent fda advisory committee voted to greenlight johnson & johnson's coronavirus vaccine. that paves the way for the fda to grant emergency use authorization. >> there is a shortage of vaccine that are currently authorized and i think authorization of this vaccine will help meet the need at the moment. >> reporter: the vaccine is slightly less effective than the moderna and pfizer shots overall, but showed 85% efficacy against severe illness. and complete protection against covid-19 death, 28 days after getting the shot. >> paid particular attention. >> reporter: it also has advantages the others do not. it can be stored at normal refrigeratio

johnson & johnson. the fda calls johnson & johnson's vaccine safe to use, clearing one hurdle in the evaluation process. the agency's independent advisers will meet to discuss the vaccine on friday and could recommend the fda authorize it for emergency use. the formal decision could come just days later. abc7 news reporter lyanne melendez joins us live from the newsroom with a look at the vaccine options now on the table. lyanne? >> i'm here to tell you why the medical community is enthusiastic about vaccine number three. and that is because they are focused on two things, keeping people out of hospitals and keeping people alive the johnson & johnson vaccine does that very well. the johnson & johnson covid-19 vaccine will add to the much needed supply to combat the pandemic. here's how it stacks up against the other two vaccines. only one shot is needed, while moderna and pfizer require two. the johnson & johnson vaccine can be stored in a refrigerator for up to three months. the other two vaccines need to be kept in ultra cold freezers. its overall efficacy rate is 72% in the u.s. and when it comes to

johnson & johnson vaccine is 85% effective at preventing severe illness. it will make it easier to distribute across the state is the basic storage requirement. >> there's not a storage issue and there's not the need for the dramatic go dramatic cold degrees the other vaccines need. >> reporter: johnson & johnson says they're on track to deliver 100 million doses by the end of june. governor gavin newsom says california is set to receive the first batch next week if authorized. >> we anticipate receiving 380,000, 380,300 doses of the j & j vaccine next week, and predictably over the next three weeks. >> reporter: another aspect that will impact distribution is the statewide system. by march 31st, california is expected to be switched over to a centralized vaccine appointment and delivery system by blueshield. dr. michael wasserman is part of the california vaccine advisory committee. he says more doses will be able to reach vulnerable populations now. >> primary care physicians who know who their patients are that need to be vaccinated, hopefully, we'll be able to get the vaccine into their offices. >> reporter: with more vaccine available, dr. gans says we have a better chance at beating the virus and reaching herd immunity faster. >> only about, i think, 13% of our population is ac

& johnson can make it. >> reporter: the johnson & johnsoncine appears highly effective against the coronavirus. the company reports that it is 85% effective against preventing severe illness and 100% effective against hospitalization and death. by the end of june, it's now possible we could have enough vaccine supply for all of america. johnson & johnson expects to produce 100 million single-dose vaccines covering 100 million people. moderna and pfizer both two-dose vaccines expect to produce 600 million doses covering 300 million people. that's more than enough to vaccinate every american adult by the end of summer, a goal set by the president. across america, about 66 million doses of the two-dose vaccines have been put into arms and about 50 million of those shots have happened since president biden took office. the president's goal was 100 million shots in his first 100 days in office. and with one month in, he's already half the way there. but he still says he's not celebrating yet. >> while things are improving this is not a victory la

johnson vaccine has been 100% effective against hospitalization and death, and 85% effective at preventing severe illness. while its overall effectiveness was lower than pfizer and moderna, johnson & johnson's was testing against concerning variants and it still performed well. >> this vaccine is going to keep you out of the hospital, it is going to keep you out of the intensive care unit, and it is going to keep you from dying. >> reporter: the next step, an independent advisory panel at the cdc will hold an emergency meeting on sunday to review the data and make a public health recommendation on the use of the latest vaccine. as early as monday, 3.9 million doses will be shipped out of two locations, one in memphis and the other in louisville, kentucky. demand for vaccinations has outweighed supply. johnson & johnson's vaccine requires only regular refrigeration, making for easier shipping and storage. multiple states have been easing restrictions, but officials warn it may be too soon. president biden releasing a statement tonight saying in part, though we celebrate today's news, i urge all americans, keep washing your hands, stay socially distanced, and keep wearing masks. >> it is impo

how johnson & johnson's one dose shot will help in the pandemic.rican voices." ey n', get the show on, get paid ♪ ♪ and all that glitters is gold ♪ get 5 boneless wings for $1 with any handcrafted burger. only at applebee's. what do we want for dinner? with any handcrafted burger. burger... i want a sugar cookie... wait... i want a bucket of chicken... i want... ♪♪ it's the easiest because it's the cheesiest. kraft. for the win win. ♪ ♪ this is my body of proof. proof of less joint pain and clearer skin. proof that i can fight psoriatic arthritis... ...with humira. humira targets and blocks a specific source of inflammation that contributes to both joint and skin symptoms. it's proven to help relieve pain, stop further irreversible joint damage and clear skin in many adults. humira can lower your ability to fight infections. serious and sometimes fatal infections, including tuberculosis, and cancers, including lymphoma, have happened, as have blood, liver, and nervous system problems, serious allergic reactions, and new or worsening heart failure.

johnson asked the fda for emergency use authorization for its vaccine. it's been months since pfizer and moderna went through that. johnson & johnson and moderna's 95% efficacy, but it doesn't need ultra cold storage and it doesn't need a second dose. >> this is a single shot vaccine in which you start to see efficacy anywhere from seven to ten days following the first and only shot. >> the company says 100 million doses by the end of june if the fda authorizes johnson & johnson to start distribution by the end of this month. we are on vaccine watch because this is a big part of building a better bay area. today we sent reporters out across the bay area to get a progress check on how distribution is going, and we're going to begin in the east bay with abc7 reporter leslie brinkley. >> this is fun. i didn't know we're going to have so much fun. >> reporter: this 84-year-old was thrilled to score a vaccine at the soft opening of this new vaccine site at the golden fields race park in albany. it's huge with a maze of cones to navigate. >> our goal here is to work out some of the kinks, figure out where we can be more efficient and rea

johnson & johnson's covid vaccine. it has two more hurdles to clear with the cdc which will begin later today. after that johnson's ready to begin shipping doses immediately. this is the third vaccine to receive an emergency use authorization in the u.s. >>> president joe biden hailed authorization of the johnson & johnson vaccine, he says the more people get vaccinated the faster the country will overcome the virus, but he also warned that the fight is far from over. cnn's arlette saenz traveled with the president and filed this report. >> reporter: president biden praised the fda's emergency authorization of the johnson & johnson vaccine as this vaccine really adds another tool to the the coronavirus pandemic. the president released a statement saying this is exciting news for all americans and an encouraging development in our efforts to bring an end to the crisis. the president went on to thank the scientists who developed this vaccine and talked about the importance of vaccinations and also maintaining social distancing and hand washing during this pandemic. he added at the end, there is light at the end of

johnson after the break we'll get. >>details from an infectious disease expert. >>well back to our top story tonight an fda panel has endorsed the johnson and johnson single dose covid-19 vaccine could be authorized for emergency use as soon as this weekend make the johnson johnson shot a 3rd vaccine authorized for emergency use in the u.s. vaccinations are picking up speed but. >>new supplies and doses are urgently needed to stay ahead of the mutated virus. it has already killed more than 500,000 americans joining us local infectious disease expert doctor, peter, chin-hong with ucsf thank you doctor as always for sharing time with us ok now the johnson johnson close to approval. >>how much does this affect the timeline and getting back to some kind of normal. >>well i think it's going have a big impact on the timeline to clean the timeline eminently for both searing the supply chain. i did to the fact that pfizer and moderna promise more doses i think going to probably the 600 million doses of pfizer moderna and 100 million doses of stuff, jane j by july. >>well, there's 300 million americans so it sounds like everybody would be covered. i think so you know we were

johnson vaccine. people who may be unlikely to follow up for a second shot because they're transients, they're not in one location very long, may be good candidates for the johnson & johnson vaccine. we have to think different vaccines for different people. >> would it make sense, sanjay, if you're going to get the johnson & johnson single-dose vaccine to get a second dose, a booster shot three or four weeks later, which is the case, of course, with moderna and pfizer? >> that exactly question, that trial is being done now. johnson & johnson start this had trial in november of last year, basically adding in a second shot. i can tell you that if you look at the immunity from this vaccine, it increases steadily. so at 28 days, it seems better than 14 days. when you get to around two months, that's when it starts to plateau. so, there may be a case made that around the time that the immunity is starting to plateau that a booster shot is given. so, we have to see what those trial data show. same thing, same sort of questions are being asked at moderna and pfizer. would boosters of some sort be beneficial? hopefully, we'll have some data soon on that. >> will people be able to

in this case, they all said get the johnson & johnson vaccine. it's safe, could save your life.on't worry, just do it. get the vaccine as quickly as possible. which is exactly what you're saying. a lot of americans have been vaccinated already. and they seem to be unclear as to what they can and can't do. and this is where i need your help. when will guidance be coming out to help answer those specific questions? because people want to know, if you're a grandparent, for example, you have gotten both shots already. it's been two or three weeks after the second dose. can you go ahead and meet with the grandkids or not? >> it's a great question, wolf, and cdc is working on that right now. the problem we have, which has not been resolved, there was a little discussion about it today, is whether the vaccination actually prevents you from being able to carry the virus, even if you don't have any symptoms. and if so, could you then be spreading it to other people around you. that is still possible, which is why we're telling everybody, even after the vaccination, you need to wear your

& johnson one which it can with that refrigeration requirement. >> reporter: johnson & johnson is designed as a one-dose vaccine, but if that's what you get, there later on anything about j&j that would preclude you from getting a different vaccine down the road, say moderna or pfizer maybe to produce the ever skafficaeffica? >> this is a question a lot of people are asking us before the vaccine is released. what people should know right now there is no need to worry about that. now, as we progress through spring and through summer, and we look to see what happens with the variants, it's possible that some of these vaccine manufacturers may have to release boosters or tweak the vaccines. so it's entirely possible that people who got any vaccine, whether it be johnson & johnson, pfizer, moderna, may need another shot or booster. but right now it's not something i would worry about. what i would focus on is that the j&j vaccine is more than 80% effective in preventing the hospitalizations, severe illnesses. when you combine it with all the other safety factors we're putting in pl

johnson & johnson vaccine already got an endorsement from staffers earlier this week. a thumbs was was given for emergency use authorization saying the benefits outweigh the risk. this advisory board spent hours today discussing the johnson and johnson vaccine before the final vote which came down this afternoon. the vaccine requires just one shot and can be kept in a nor mall fridge. it's more than 80% effective. the trials went well but there were some reactions. sciencetists for johnson & johnson's vaccine division elaborated more at today's meeting. >> on wednesday of this week we received preliminary reports of two cases of severe allergic reaction. one from an ongoing open label collaborative study in south africa. in summary the known and potential benefits out yn weigh the known and potential risk. >> board members seem to agree saying the vaccine checks nearly all the boxes. johnson & johnson says it can deliver four million doses right away. 21 million next month and 100 million over next few months. a trifecta of vaccines appear to be on the way. probably in next two or three days and like moderna and pfizer, johnson & johnson will start vaccine trials on children. in reality if children want to get vaccinated

even more important but we have to understand this vaccine, johnson & johnson, you can't entirely compare it to the derma and pfizer because johnsonan variants were as the moderna vaccine and pfizer did not. that is why they are working on up booster vaccine. johnson and johnson right now is only 72% effective with one dose but they are looking to see if you get a second dose will that bump you up to the 95-96% like we see in moderna vaccine and pfizer and those tests are being taken right now and it's just a nap a matter of waiting for that data to come out. arthel: but you mention variants because were now learning of another new variant. the new york variants. this is what has people so nervous. you got people who have been fully vaccinated and it had ande hearing and correct me if i'm wrong here but even you are saying that there is still not a guarantee that those people who have already been fully vaccinated will be protected from some of these new variants that continue to crop up where as the johnson & johnson shot was tested against the possibility of variance in that it may be more effective in that regard. >> possibly.

johnson & johnson one-shot vaccine. governor newsom says california will get about 350,000 doses of the first batch of the johnson & johnsoneasier to distribute because it doesn't need to be kept in cold temperatures. this comes as the state prepares to switch over to a more centralized vaccine and delivery system hosted by blue shield march 31st. >>> coming up on "this week" dr. anthony fauci will talk about what's coming next. you can watch that full interview at 8:00 this morning on abc7. >>> let's check the weather with meteorologist lisa argen. >> good morning to you. we have a lot of clear sky here. this is emeryville, some light north winds. it is 50 in san francisco. 51 in oakland. it's chilly in the upper 30s in morgan hill, half moon bay at 50. this is san jose, 80. numbers are in the upper 50s for livermore and santa rosa. 44 in concord. we have a lot of sunshine on the way today. winds are easing up. you can see upper elevations still quite gusty with offshore winds. those northerly wind also allow for numbers to be mid to upper 60s for oakland and concord. a few 70s out there. a light onshore flow late in the

that new johnson & johnson vaccine clearing a huge hurdle today. an fda panel endorsed it, and any day now the fda will give its final stamp of approval. if approved, it will be the first single-dose covid vaccine in the united states. another difference, it can be kept in a normal fridge, that temperature, so it's easier to appears effective against the new variants of the virus. final approval could come as early as this weekend. so what does that mean for us here in california? governor newsom says the j&j doses could arrive here by next week. he made the announcement today during a visit to fresno county. the governor says the first batch of doses for our state

johnson & johnson vaccine. nbc' we're talking about tomorrow. the fda is expected to grant johnson & johnson emergency approval, emergency use approval of its new vaccine. that will be&j vaccine awaiting approval from an fda panel. that expected tomorrow. the johnson & johnson vaccine is 72% effective which is less effective than the moderna and pfizer vaccines which have efficacy rates in the 95% range, but the johnson & johnson vaccine would still be more effective than, say, your average flu shot, and johnson & johnson is just one dose and it does not require special refrigeration. >> super promising. and two weeks ago we were seeing why are we reopening huge centers when we don't have enough vaccine? i think it was important to open them up because once we get the supply in, you have the infrastructure. >> reporter: and this week, both moderna and pfizer told congress that they hope to have an additional 140 million doses out within the next five weeks with a goal of 28 million doses per week. reporting live, bob redell, nbc bay area news. >> thank you. >>> new video at 11:00 o

if an eua, we anticipate allocated 3 million to 4 million doses of johnson & johnson vaccine next week. johnson & johnson announced they aim to deliver 20 million doses by the end of march. we are working with the company to accelerate the pace and time frame by which they deliver the full 100 million doses, which is required by contract by the end of june. while we await the fda's decision, we want the american people to know that we are doing the work so that if the eua is granted, we will waste no time getting this life saving vaccine into the arms of americans. with that let me turn it over to dr. walensky to talk about the state of the pandemic. >> thank you. i'm delighted to be with you today. we continue to see trends heading in the right direction. in the past week, average daily cases declined 25% to approximately 64,000 cases per day. this is slightly less than the summer peak of 67,000 daily cases reported last july. while this is good news, cases still remain high. we continue to watch these data closely. we also see decline in new hospital admissions for the most recent week. a dec

a key fda meeting on the johnson & johnson jab.y 26th, 2021, that means march is coming "squawk box" begins right now. ♪ >>> good morning, everybody. welcome to "squawk box" here on cnbc i'm becky quick along with joe kernen and andrew ross sorkin. and we're going to start like we always do with the markets, especially after yesterday's selloff. the dow was down by 559 points during the session that was a decline of 1.8% it slipped from a record high. in fact, we were almost at 32,000 the session before that you ended up closing at 31,402 yesterday. and by the way, the dow was the best performer out of the three major averages the s&p was down by about 2 1/2%, and then the nasdaq's loss of 3 1/2% was

. >> if the johnson & johnson vaccine is approved, it could be a became changer. >> tonight, johnson & johnson is applying for emergency use authorization for the single dose vaccine. >> kate larson on why kit be pivotal against covid very absolutely. it's on a different platform hope iet r andmorn vaccines out more quickly in time to slow or stop new variants. a third vaccine on the verge. johnson & johnson applying for emergency use authorization in the u.s. it's just one shot. shown to be 100% effective in preventing of theizations and deaths. >> i'm so excited about it. this is like yes. >> we were there as richmond resident britt garcia volunteered for the trial in november. >> being hispanic, older, overweight. i really felt an obligation to participate. >> the participants really represent the community. >> reporter: the co-investigator of the trial says not to compare the overall efficacy to moderna. johnson & johnson is 66% effective in moderate to severe. and moderna and pfizer are 95%. and that is before the new variants. >> it's not really apples to apples. >> she says it'

& johnson vaccine be more effective if there were a booster three or four weeks later, you got a second johnson & johnsonhot, as is the case with moderna and pfizer vaccines? >> that's a great question. that clinical trial is happening right now. we don't know. if i'd just speculate i think it's possible that we may find that a second dose of the j&j may be a really helpful thing. i think we'll know more in the next couple of months. that trial is happening even as we speak. >> one shot is great, but if two shots might be even better, but we shall see. we know that these vaccines, dr. jha, are very good at preventing severe disease, hospitalizations, deaths. but as dr. fauci said today, it was pretty alarming, so many people who have had mild or moderate cases of the virus often have symptoms, serious symptoms, painful symptoms that linger for several months. are you optimistic that these vaccines will prevent these kinds of chronic symptoms? >> you know, i am. again, we don't know but we haven't seen a lot of people who got these vaccines who then ended up having those long haul symptoms. so i'm hopeful

chance between getting the moderna or pfizer vaccine two months from now or johnson & johnson today, i would say get the johnsonoing to protect you from what we care about, which is ending up in the hospital or dying. there were zero deaths in the people that got the j&j vaccine after 28 days post vaccination. that's just amazing. >> so important to point that out. johnson & johnson says it will begin testing its covid-19 vaccine in adolescents next week. a lot of parents are wondering when this is going to take place, that their children can get vaccinated. how important is it to get a vaccine authorized for children? >> it's particularly important for those older age groups, really age 12-plus who we know are more likely to catch and transmit the virus. for the younger age groups, it would be lovely to get them vaccinated. we don't need that in place in order to get schools back to said. that said, if i had a chance i would sign my kids up for a trial and when the vaccine is approved for kids, i hope all of us as parents go out and get our kids vaccinated as well. >> covid-19 hospitalizations fell to less tha

. >> if the johnson & johnson vaccine is approved, it could be a became changer. >> tonight, johnson lying for emergency use authorization for the single dose vaccine. >> kate larson on why kit be pivotal against covid very absolutely. it's on a different platform than pfizer and moderna. the hope is that kit help get vaccines out more quickly in time to slow or stop new variants. a third vaccine on the verge. johnson & johnson applying for emergency use authorization in the u.s. it's just one shot. shown to be 100% effective in preventing of theizations and deaths. >> i'm so excited about it. this is like yes. >> we were there as richmond resident britt garcia volunteered for the trial in november. >> being hispanic, older, overweight. i really felt an obligation to participate. >> the participants really represent the community. >> reporter: the co-investigator of the trial says not to compare the overall efficacy to moderna. johnson & johnson is 66% effective in moderate to severe. and moderna and pfizer are 95%. and that is before the new variants. >> it's not really apples to app

johnson & johnson tonight. so, this evening, what does this all mean for the timeline? could vaccinations happen sooner, even if it's just a week sooner? and we're tracking more fema vaccination sites opening today. this one in queens, new york, aiming to administer 3,000 shots a day. this one in houston tonight, hoping for 6,000 shots a day. so, this evening, what you need to know about this new one-shot vaccine and how soon could we see it? dr. jha standing by and abc's eva pilgrim leading us off. >> reporter: tonight, just days away from potential emergency use authorization, the u.s. is now likely on the verge of a third vaccine and this time, a single dose and the news is promising. new analysis today finding the johnson & johnson one-dose vaccine safe and effective, 86% effective for preventing severe illness in the u.s. alone and 100% effective in preventing hospitalizations or deaths. and another key finding -- the report saying the single dose vaccine may also prevent some asymptomatic disease, when you don't even know you have it. which means it could help reduce the spread of the virus. >> preliminary analysis suggests that the vaccine provides a 74% protection against asymptomatic disease, which is important because if you can prevent asymptomatic disease, then you will also reduce transmission. >> reporter: the fda saying the vaccine had the expected side effects, like fever and fatigue, but no reports of severe allergic reactions. >> overall, the vaccine provides very robust protection throughout the world, including against the worrisome viral variants. >> reporter: so, what does this mean for the vaccine supply in the u.s.? johnson & johnson says it could have 3 to 4 million doses sent out

& johnson vaccine. >> next, president rama posa is the first to be inoculated in south africa. using the johnson & johnsoncine. south africa received one million doses of the astrazeneca formula but decided against using it over concerns weather will protect against the widespread varnt. a maternity nurse at a hospital in cape town was the first to be immunized, after the first batch of 80,000 doses landed in the country from brussels. >> a second chance to roll out a vaccine in south africa, as a nurse in cape town is the first dose of the serum from johnson & johnson. she will be followed by president rama posa. he led by example. >> yes. it's going in. >> rama posen needed special dispensation since early doses were earmarked for frontline health workers. the first batc arrived overnighth and replaces the astrazeneca version of which south africa had initially procured one million doses. however, it was not found effective enough against a local widespread variant of the coronavirus, leading to a rush for a new solution. the johnson & johnson shot hasn't yet been authorized for general use worldwide. b

& johnson single shot vaccine. >> it is a single dose regimen. >> reporter: a panel of experts recommending authorization friday after trials have shown the johnson & johnson% effective against severe disease and 100% effective against hospitalization and death. with two out of 400,000 trial participants reportedly having suspected severe allergic reactions. doses can be stored and shipped in normal refrigerators. upon authorization, the 3 to 4 million doses already available could start to ship out as early as monday. with a goal of 20 million by the end of march, and 100 million by june. >> we have three highly effective vaccines. you look at the data and it is clear that you get essentially no hospitalizations or deaths. >> reporter: states are ramping up infrastructure, making up for delays caused by last week's winter storm. three new york city sites are offering shots 24/7 now that they have a surplus of doses. the 101st airborne going to orlando, one of five units to help in florida and philadelphia. illinois expanding eligibility criteria to millions more people. >> i am a two time cancer survivor, had a stem cell transplant. i mean even though it

johnson & johnson under the prior administration. across the last few weeks, we've learned that there is not a big inventory of johnson & johnson. there's a few million doses that we'll start with. the johnson & johnson contract commits johnson & johnson to deliver 100 million doses by the end of june. that is more back-end loaded. we're working with the company to do everything we can, assuming they are approved by the fda, to bring forward as many of those doses as possible into the earlier months. so i want to be clear that johnson & johnson has 100 million commitment, for the end of june, of doses. at the same time, we're going to be starting with only a few million in inventory, and we're doing everything we can, working with the company, to accelerate their delivery schedule. moderator: next we'll go to ed o'keefe at cbs. reporter: hey guys, how are you? thank you for doing this again. two things. first, can you give us a sense of how the weather situation, especially in texas, might be affecting vaccine distribution rollout and testing, for that matter? a lot of vaccine appointments would have been canceled in texas, or ot

johnson & johnson vaccine. the newest weapon against covid here in the u.s., johnson & johnson's vaccine 85% effective against severe cases of covid. 100% effective at preventing hospitalizations and deaths. it could be stored in normal refrigeration. how many doses will be shipped right away? how many next month? and what you need to know about this one-shot vaccine that many are calling a game changer. >>> also tonight, the biden administration declassifying the report on the murder of u.s.-based journalist jamal khashoggi, pointing the blame at saudi arabia's crown prince, accusing him of approving the brutal attack. the sanctions just issued tonight, but not for the crown prince. martha raddatz with late reporting. >>> we're also learning more about president biden's first known military action, the air strike in syria. who was targeted. the action and retaliation for an attack that killed a contractor and injured u.s. service members in iraq. >>> president biden in texas today after the devastating storms. after millions lost power for days, boiling their water, and some then getting bills for thousands for jus